Clonazepam

ADVERTISEMENT

Identification

Molecular formula
C15H10ClFN2O
CAS Number
1622-61-3
IUPAC Name
7-chloro-1-[3-(dimethylamino)propyl]-5-(2-fluorophenyl)-4,5-dihydro-3H-1,4-benzodiazepin-2-one
Molecular Weight
315.72g/mol
Melting Point
(Celsius)
Boiling Point
(Celsius)
Density
1.5490g/cm3
Interesting facts

Interesting Facts about 7-Chloro-1-[3-(dimethylamino)propyl]-5-(2-fluorophenyl)-4,5-dihydro-3H-1,4-benzodiazepin-2-one

This compound is a fascinating member of the benzodiazepine class, which is widely known for its psychoactive properties. Benzodiazepines play a crucial role in medicinal chemistry, particularly in the treatment of anxiety, insomnia, and other central nervous system disorders.

Chemical Structure and Functionality

The unique structure of this compound, featuring both chlorine and fluorine substituents, contributes to its distinctive chemical behavior and biological activity. Here are some notable aspects:

  • Haloalkyl Groups: The presence of both a chlorine atom (7-chloro) and a fluorobenzene moiety introduces unique electronic effects that stabilizes the compound's receptor binding.
  • Dimethylamino Group: The dimethylamino propyl side chain (3-(dimethylamino)propyl) enhances its lipid solubility, facilitating better absorption in biological systems.

Pharmacological Implications

This compound exhibits a range of pharmacological activities, primarily due to its interaction with the GABAA receptor:

  • Anxiolytic Effects: As a modulator of GABAA receptors, it is known to produce calming effects, making it effective for anxiety relief.
  • Hypnotic Properties: It has sedative qualities that can induce sleep, being useful in the management of sleep disorders.

Research and Development

Given its complex structure, this compound is a subject of continuous research, aimed at improving its therapeutic profile. Scientists are particularly interested in:

  • Developing derivatives with reduced side effects but enhanced potency.
  • Exploring its potential for treating various neurological conditions beyond anxiety and insomnia.

As we delve deeper into the chemistry of such compounds, the balance between efficacy and safety remains a pivotal area of study, emphasizing the importance of structure-activity relationships in drug design.

ADVERTISEMENT